Dominique Fontanilla

@Datamonitor_HC. Views expressed are my own

[Scrip, Citeline Commercial @PharmaScrip]

Patents And LOEs Poised To Be Hot Q2 Topics
https://t.co/w8HuekssQi #PharmaScrip

[Scrip, Citeline Commercial @PharmaScrip]

Acadia’s Launch Of Daybue Astonishes Analysts
https://t.co/SHE1Fo2fDH #PharmaScrip

[Citeline @Citeline]

Do you work with #CDMO partnerships when it comes to #drugdevelopment? What are the challenges or opportunities have you encountered? Tell us your thoughts in this short survey https://t.co/pKlgr6pOWz

[Citeline @Citeline]

Did you see our winner of the Lifetime Achievment Award at the 2020 #ScripAwards? Dame Sally Davies had this to say: "I've never been prouder to be part of an industry that innovates and collaborates."
Be part of the 2021 #ScripAwards & Enter today https://t.co/y4N0So10GS

[Pamela Spicer @Datamonitor_PS]

$BMY declares deucravacitinib as first in new TYK2-selective class to differentiate from JAKs #AADVMX2021
https://t.co/0BsM3LWlgX

[Medtech Insight, Citeline Commercial @Medtech_Insight]

Diagnostics Saves Roche From Q1 Losses
https://t.co/mSdQQ2tztW

[Citeline @Citeline]

Just a few more hours until #IQVIA discuss the modern #RegulatoryOperations process and how current & future technologies there are to support the adoption of new standards. Have you registered yet? https://t.co/E1CIsPJKlm

[Citeline @Citeline]

Get the perspective of #CDMO partnerships from 3 different #pharma companies in this summary report from #Cambrex. Download your copy today https://t.co/zZXbHEXGdn

[Citeline @Citeline]

The 2021 #CitelineAwards are designed to champion excellence across the spectrum of key R&D activities. The deadline for entries is the 16th July 2021. Enter now and be recognised for your work! https://t.co/m7Z3YjmcC0

[Citeline @Citeline]

Publishing has been a core comptency of #Regulatory Operations & has evolved in many ways since paper publishing was first introduced. Join us on Thursday as we discuss the modern process & the future trends. Register today https://t.co/A5D8DKAkx8

[Citeline @Citeline]

What do you look for when partnering with a #CDMO? Is it a cultural fit? Capacity? Or is it technical expertise? Find out more about #CDMO partnerships in this report from #Cambrex https://t.co/BzUfVhQcVw

[Citeline @Citeline]

Calling #PinkSheet Subscribers! Are you putting your organization at risk for non-compliance for your #clinicaltrials. Sign up to receive a free assessment from #TrialScopeDisclose here https://t.co/v6SZfOieml Offer ends April 28th 2021

[Citeline @Citeline]

Learn how #CitelineConnect supported the fastest-recruiting #covid19 #clinicaltrial in operation Warp Speed history. Watch this insightful #webinar-on-demand here https://t.co/BJmahqasUl

[Medtech Insight, Citeline Commercial @Medtech_Insight]

Exec Chat: CHF Solutions Focused On Expanding Access To Aquadex Ultrafiltration
https://t.co/ZOBrr4UNQh

[Medtech Insight, Citeline Commercial @Medtech_Insight]

US FDA Panel Grapples With Dermal Filler Adverse Events
https://t.co/kghFxmbowk

[Scrip, Citeline Commercial @PharmaScrip]

Slaoui Apologizes For Sexual Harassment, Loses Further Industry Roles
https://t.co/5viCrJS0oN #PharmaScrip

[Pharma Ignite @PharmaIgnite]

#Pharma industry leaders, R&D analysts & innovators will gather virtually on April 20th & 22nd, to discuss the state of play in the world of #PharmaRnD. Register here https://t.co/08HkPNuk7w

[Citeline @Citeline]

Will you be joining us next week as we discuss the predictions & trends for when #clinicaltrials return to 'normal'. Register your space here & join us next Tuesday at 10am ET. https://t.co/JlFsTYNDqs

[Citeline @Citeline]

Don't forget to register for our #webinar with #STAPharmaceuticals. Tomorrow at 11am ET, we will be discussing real cases where unexpected concerns from #regulatory reviewers impacted program launch. Register your spot here https://t.co/Tk1G9sOnby

[Citeline @Citeline]

What are the opportunities & challenges when it comes to end-to-end #drug development partnerships? Download this summary report from #Cambrex here https://t.co/JZDBpo5FOM